Patient 28 with a high-grade neuroepithelial tumor with MN1 alteration (HGNET-MN1-altered) and a TSC2 mutation was treated with everolimus with SD over twelve months (Fig. 3B, Table 1). Here, TSC2 is linked to neuroepithelial neoplasm.